Molecular diagnostics company NanoString Technologies Inc. (NASDAQ:NSTG) hired Thomas Bailey as CFO. He was CFO of AgaMatrix Holdings LLC (Salem, N.H.).
Gene therapy company Orchard Therapeutics Ltd. (London, U.K.) hired Frank Thomas as CFO and CBO. He was president and COO at AMAG Pharmaceuticals Inc. (NASDAQ:AMAG).
Generics company Hikma Pharmaceuticals plc (LSE:HIK) hired Surendera Tyagi as group CSO and global head of R&D. He was head of the U.S. Innovation & Development Center at the Fresenius Kabi subsidiary of Fresenius SE & Co. KGaA (Xetra:FRE; OTCQX:FSNUY).
Cancer immunotherapy company Immatics Biotechnologies GmbH (Tübingen, Germany) hired Thomas Ulmer as CFO, effective April 1. He is CFO of the Allergopharma GmbH & Co. KG unit at Merck KGaA (Xetra:MRK).
Antibody-drug conjugate (ADC) developer Glythera Ltd. (Newcastle upon Tyne, U.K.) hired Robert Lutz as CSO. He was VP of translation research and development at ImmunoGen Inc. (NASDAQ:IMGN).
Genomics company Sequence Bio Inc. (Newfoundland, Canada) hired Michael Phillips as CSO. He was VP of genomics at Genomics Medicine Ireland Ltd. (Dublin, Ireland).
Biomanufacturing company Selexis S.A. (Geneva, Switzerland) appointed Alberto Garotti CFO. He was president at Evolve Consulting S.a.r.l. (Coppet, Switzerland).
Diagnostic company Immucor Inc. (Norcross, Ga.) hired Avi Pelossof as president and CEO. He succeeds Jeffrey Binder, who will remain chairman. Pelossof was the global president for the infectious disease business of Alere Inc., which Abbott Laboratories (NYSE:ABT) acquired last year.
(C) 2018 M2 COMMUNICATIONS, source M2 PressWIRE